Cardlytics (CDLX) EBITDA margin US GAAP (year values)

2020 2021 2022 2022 2023   LTM ? CAGR 5 years ?
EBITDA margin, % ? -21.1% -33.7% -139.9% -140.3% -32.0%   -81.4%  
Changes by years, y/y, % -15pp -13pp -106pp 0pp +108pp     +9.3%

Cardlytics. EBITDA margin, %

Cardlytics. EBITDA margin, changes, pp

Cardlytics (CDLX) EBITDA margin US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
EBITDA margin, % ? -19.8% -103.4% -24.6% 7.51% -201.8%   -81.4%
Changes by years, y/y, % +14pp -81pp +11pp +25pp -182pp    
Changes by quarters, q/q, % -2pp -84pp +79pp +32pp -209pp    

Cardlytics. EBITDA margin, %

Cardlytics. EBITDA margin, changes, pp

Cardlytics. EBITDA margin, changes, pp